Cd160 pe

Manufactured by BioLegend

Sourced in United States

CD160-PE is a fluorochrome-conjugated antibody that binds to the CD160 cell surface receptor. CD160 is a glycosylphosphatidylinositol (GPI)-anchored glycoprotein that is expressed on a subset of natural killer (NK) cells, cytotoxic T cells, and intestinal intraepithelial lymphocytes. The PE (phycoerythrin) fluorochrome allows for the detection and analysis of CD160-expressing cells using flow cytometry.

Automatically generated - may contain errors

Lab products found in correlation

Cd45ra ecd, by Beckman Coulter (1 mentions) Cd8 pb, by BD (1 mentions) Cd3 apc h7, by BD (1 mentions) Il 2 pe, by BD (1 mentions) 2b4 pe cy5, by BioLegend (1 mentions) Cd160 apc, by BioLegend (1 mentions) Ccr7 fitc, by R&D Systems (1 mentions) Ifn γ af700, by BD (1 mentions) Cd8 efluor625nc, by Thermo Fisher Scientific (1 mentions) Pd 1 pe cy7, by BD (1 mentions) Cd4 pb, by BD (1 mentions) Cd4 ecd, by Beckman Coulter (1 mentions) Ctla 4 apc, by Beckman Coulter (1 mentions) Cd127 cy5pe, by BioLegend (1 mentions) Ccr7 bv605, by Thermo Fisher Scientific (1 mentions) Cd4 cy55pe, by Thermo Fisher Scientific (1 mentions) Cd45ra cy7pe, by Beckman Coulter (1 mentions) Btla pe, by BioLegend (1 mentions) Pd 1 bv421, by BioLegend (1 mentions) Cd27 qd605, by Thermo Fisher Scientific (1 mentions)

2 protocols using cd160 pe

Multiparameter Flow Cytometry Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols

The following monoclonal antibodies (mAbs) were used in different combinations. CD8-PB, CD3-APC-H7, PD-1-PECy7, PD-1-PB, IFN-γ-AF700, IL-2-PE, CD4-PB, granzyme B-AF700, perforin-APC were purchased from Becton Dickinson (BD, San Diego, CA), CD45RA-ECD, CD4-ECD from Beckman Coulter (Fullerton, CA, USA), CCR7-FITC from R&D Systems (Minneapolis, MN, USA), 2B4-PECY5.5, CD160-APC, CD160-PE from BioLegend (San Diego, CA, USA), CD4-eFluor650NC, CD8-eFluor625NC from eBioscience.

Viganò S., Banga R., Bellanger F., Pellaton C., Farina A., Comte D., Harari A, & Perreau M. (2014). CD160-Associated CD8 T-Cell Functional Impairment Is Independent of PD-1 Expression. PLoS Pathogens, 10(9), e1004380.

+ Open protocol

+ Expand

Comprehensive Immune Phenotyping by Flow Cytometry

Check if the same lab product or an alternative is used in the 5 most similar protocols

Flow cytometry was performed using the following directly conjugated antibodies:
(1) BD Biosciences: CD3-H7APC (SK7), CD45RA-Cy7PE (L48), CTLA-4-APC (BNI3),
IFN-g-FITC (B27), CCR7-Alexa700 (150503), CCR5-FITC (2D7/CCR5), CCR4-PE (1G1) and
IL-2-PE (MQ1-17H12), Ki67-FITC (B56); (2) Beckman Coulter: CD27-Alexa680
(IA4CD27), CD127-Cy5PE (R34.34), CD160-PE (BY55), BTLA-PE (J168-540); (3)
BioLegend: PD-1-BV421 (EH12.2H7), 2B4-FITC (CD244, C1.7), IL-17a-Cy5.5PerCP
(BL168), CCR6-Alexa647 (or PE, TG7/CCR6), CD27 Alexa647 (O323), CCR7 BV605
(G043H7), CXCR5 BV421 (J252D4), and CD154-Cy5PE (24–31); (4) Invitrogen:
CD4-Cy5.5PE (S3.5), CD27-QD605 (CLB-27/1), CD8-QD800 (3B5). A biotinylated
anti-PD-1 antibody was obtained from R&D (BAF 1086) and streptavidin-Qdot
655 was obtained from Molecular Probes. Quantum dots and Aqua amine viability dye
were obtained from Invitrogen. CD27-Alexa 594, TNF-a Alexa 594, HLA-DR BV650, and
CD38-Alexa 680 were conjugated in-house.

Paris R.M., Petrovas C., Ferrando-Martinez S., Moysi E., Boswell K.L., Archer E., Yamamoto T., Ambrozak D., Casazza J.P., Haubrich R., Connors M., Ake J., Kim J.H, & Koup R.A. (2015). Selective Loss of Early Differentiated, Highly Functional PD1high CD4 T Cells with HIV Progression. PLoS ONE, 10(12), e0144767.

+ Open protocol

+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Revolutionizing how scientists
search and build protocols!